OneMedNet Updates Prospectus with Q1 Financials
OneMedNet Corporation (NASDAQ: ONMD) has filed a Rule 424(b)(3) prospectus supplement with the U.S. Securities and Exchange Commission, updating its existing registration statement by incorporating its quarterly financial results for the period ended March 31, 2026. The filing registers a primary offering of up to 11.5 million common shares while also allowing the resale of…